Outcomes of Post-Operative Treatment with Concurrent Chemoradiotherapy (CRT) in High-Risk Resected Oral Cavity Squamous Cell Carcinoma (OCSCC): A Multi-Institutional Collaboration

Outcomes of Post-Operative Treatment with Concurrent Chemoradiotherapy (CRT) in High-Risk Resected Oral Cavity Squamous Cell Carcinoma (OCSCC): A Multi-Institutional Collaboration

Adjuvant chemoradiation (CRT), with high-dose cisplatin remains standard treatment for oral cavity squamous cell carcinoma (OCSCC) with high-risk pathologic features. We evaluated outcomes associated with different cisplatin dosing and schedules, concurrent with radiation (RT), and the effect of cum...

Full description

Bibliographic Details
Main Authors: Arslan Babar, Neil M. Woody, Ahmed I. Ghanem, Jillian Tsai, Neal E. Dunlap, Matthew Schymick, Howard Y. Liu, Brian B. Burkey, Eric D. Lamarre, Jamie A. Ku, Joseph Scharpf, Brandon L. Prendes, Nikhil P. Joshi, Jimmy J. Caudell, Farzan Siddiqui, Sandro V. Porceddu, Nancy Lee, Larisa Schwartzman, Shlomo A. Koyfman, David J. Adelstein, Jessica L. Geiger
Format: Article
Language:English
Published: MDPI AG 2021-06-01
Series:Current Oncology
Subjects:
high risk oral cavity cancer
oral cavity squamous cell cancer
chemoradiation
cisplatin
cumulative cisplatin dose
cisplatin schedule
Online Access:https://www.mdpi.com/1718-7729/28/4/221

Internet

https://www.mdpi.com/1718-7729/28/4/221

Similar Items